Multifunctional DNA Polycatenane Nanocarriers for Synergistic Targeted Therapy of Multidrug‐Resistant Human Leukemia
- 16 September 2019
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 29 (48)
Abstract
Chemotherapy, as one of the principal modalities for cancer therapy, is limited by its inefficient delivery, serious side effects as well as multidrug resistance (MDR). Herein, multifunctional aptamer‐tethered deoxyribonucleic acids (DNA) polycatenanes (AptDPCs) is reported to combat MDR human leukemia. By rational design, the DNA polycatenanes (DPCs) are first constructed by a one‐step self‐assembly approach, during which DPCs are incorporated with fluorophores for bioimaging, abundant doxorubicin (DOX) intercalation sites for drug delivery, and antisense oligonucleotides (AS ODNs) for inhibiting the expression of P‐glycoprotein (P‐gp) and further reversing MDR. In addition, to endow the DPCs with specific recognition toward the target cancer cells and high purity, aptamers are tethered to the DPCs via the magnetic separation method based on the toehold‐mediated strand displacement (TMSD) reaction, which not only improves the purity and reproducibility of the AptDPCs, but also realizes the recycle of magnetic carriers. The results confirm that the AptDPCs can deliver drugs and AS ODNs into the target cancer cells and synergistically inhibit the MDR tumor growth without apparent systematic toxicity. The proposed AptDPC‐based drug delivery system can effectively reduce side effects and reverse MDR, which provides a promising platform for codelivery of therapeutic genes and chemodrugs in targeted cancer therapy.Keywords
Funding Information
- National Natural Science Foundation of China (21834004, 21722505)
- Ministry of Science and Technology of the People's Republic of China (2016YFE0130100)
- Natural Science Foundation of Shandong Province (ZR2017JL009)
This publication has 49 references indexed in Scilit:
- Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranosticsProceedings of the National Academy of Sciences, 2013
- Purification of DNA-origami nanostructures by rate-zonal centrifugationNucleic Acids Research, 2012
- Designed Synthesis of CeO2 Nanorods and Nanowires for Studying Toxicological Effects of High Aspect Ratio NanomaterialsACS Nano, 2012
- Self‐Assembled Aptamer‐Based Drug Carriers for Bispecific Cytotoxicity to Cancer CellsChemistry – An Asian Journal, 2012
- Cell-Specific, Activatable, and Theranostic Prodrug for Dual-Targeted Cancer Imaging and TherapyJournal of the American Chemical Society, 2011
- Polymer Nanoneedle‐Mediated Intracellular Drug DeliverySmall, 2011
- Programmable in situ amplification for multiplexed imaging of mRNA expressionNature Biotechnology, 2010
- Development of DNA aptamers using Cell-SELEXNature Protocols, 2010
- Molecular recognition of acute myeloid leukemia using aptamersLeukemia, 2009
- Solution structure of a purine rich hexaloop hairpin belonging to PGY/MDR1 mRNA and targeted by antisense oligonucleotidesNucleic Acids Research, 2006